Close
Nordic 9Nordic 9

ApoGlyx (private company)

Sweden apoglyx.com
See something wrong or missing? Let us know
Offices:Lund
Industry:BiotechHealth services
Business model:B2B

Apoglyx is a pre-clinical stage biotech company with the aim to develop a small molecule therapy and concepts for metabolic and inflammatory diseases, f.x. sepsis.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 700k

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to ApoGlyx

Name Criteria
Sweden VOC Diagnostics
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden PeptiSystems
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Spain Polimerbio
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Valink Therapeutics
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Novai
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden Celluminova
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Finland Sooma Medical
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Finland StemSight
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden In Singulo Solutions AB
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Spain Cornea Project
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Top